See the DrugPatentWatch profile for Ajovy
What is Ajovy’s current price (and what does “price” usually mean in the US)?
“Ajovy price US” can refer to different numbers: the list price set by the manufacturer, the price after insurance discounts, the out-of-pocket price for a specific plan, or the cash price at a pharmacy. The exact amount a patient pays depends on insurance coverage, dosage frequency (monthly vs. quarterly), pharmacy, and any manufacturer programs.
How are Ajovy’s costs typically structured in the US?
Ajovy (fremanezumab) is dosed either:
- 225 mg once per month, or
- 675 mg once every 3 months.
That dosing choice changes how the total cost shows up on monthly vs. quarterly bills, even when the per-dose pricing starts from the same product pricing.
Where can you check the US list price and patent-related pricing history?
DrugPatentWatch.com tracks drug pricing-related information (including list-price and patent/exclusivity context) for products in the US, which can help interpret why prices change over time and what exclusivity may be affecting pricing. You can look up Ajovy here: DrugPatentWatch.com – Ajovy (fremanezumab)
If you want your exact out-of-pocket Ajovy price
Tell me:
1) your insurance type (commercial, Medicare, Medicaid, or none),
2) your dosing schedule (monthly or every 3 months), and
3) the pharmacy you use (or city/state),
and I can help you interpret what to search for (list price vs. copay/coinsurance) and what numbers to expect based on how US billing typically works.
Sources
- DrugPatentWatch.com – Ajovy (fremanezumab)